Loading
No insider purchase over the last 90 days. The latest, by Phelan Kenneth J, was filed 27 Jan 2026.
Insider Decl.
12
Thresholds
n/a
Buy Volume
€85,622
8 ops. · all time
Sell Volume
€51,463
4 ops. · all time
Who traded when
BuySaleKenneth J. Phelan1 buy
Noni L. Ellison1 buy
Thomas Rowe Wright1 buy
William K. Bacic1 buy
Since the insiders bought
- -6.6%Entry US$24.23 · Close 21 Oct 2026 US$22.62
- +21.0%Entry US$21.24 · Close at T+365 US$25.69
- +6.5%Entry US$22.41 · Close at T+365 US$23.87
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended October 2025 · cache
US$22.32
Analyst consensus
Income statement
RevenueUS$106.3M
Gross profitUS$1.2B1172% margin
EBITDAUS$405.2M381% margin
Net incomeUS$105.3M234.1% margin
Valuation
PER (trailing)4.6x
P/Book0.8x
Beta0.80
Balance sheet & cash
Market capUS$790.8M
Total debtUS$427.9M
Free Cash FlowUS$52.2M
Debt / Equity44%
Profitability & ownership
ROE18.5%
ROA2.9%
% insiders0.0%
% institutions17.8%
Last declaration on 27 January 2026
Declarations12 total
415.151 shares@ US$24.09100.0% of flowCommon Shares of Beneficial InterestSEC:0001779467-26-000008:0
Canonical exit: 26 Apr 2026 (T+90)
518 shares@ US$21.30100.0% of flowCommon Shares of Beneficial InterestSEC:0001950731-25-000036:0
Canonical exit: 7 Jul 2025 (T+90)
459 shares@ US$21.97100.0% of flowCommon Shares of Beneficial InterestSEC:0001950731-25-000001:0
Canonical exit: 14 Apr 2025 (T+90)
505 shares@ US$22.3850.7% of flowCommon Shares of Beneficial InterestSEC:0001950731-24-000034:0
Canonical exit: 23 Mar 2025 (T+90)
700.649 shares@ US$21.58100.0% of flowCommon Shares of Beneficial InterestSEC:0001561793-24-000009:0
Canonical exit: 1 Apr 2024 (T+90)
650 shares@ US$17.059349.3% of flowCommon Shares of Beneficial InterestSEC:0001561793-23-000022:0
Canonical exit: 10 Jan 2024 (T+90)
800 shares@ US$25.0940.5% of flowcommon shares of beneficial interestSEC:0001228616-22-000036:1
0.23 shares@ US$25.200.0% of flowcommon shares of beneficial interestSEC:0001228616-22-000036:2
1,173 shares@ US$25.10100.0% of flowcommon shares of beneficial interestSEC:0001228616-22-000036:0
475 shares@ US$21.0316100.0% of flowcommon shares of beneficial interestSEC:0001228616-20-000041:0
Canonical exit: 15 Feb 2021 (T+90)
145 shares@ US$24.30100.0% of flowcommon shares of beneficial interestSEC:0001228616-16-000089:0
742 shares@ US$20.2432100.0% of flowcommon shares of beneficial interestSEC:0001228616-16-000059:0
Canonical exit: 3 Apr 2016 (T+90)
12 of 12 declarations
About John Hancock TAX-Advantaged Dividend Income Fund
Steven R. Pruchansky filed 3 filings at John Hancock Tax-Advantaged Dividend Income Fund, all sales: EUR 28,730 and EUR 19,587 on August 5, 2022, which make most of the fund's 4 sales, totalling EUR 51,463 (median EUR 11,364) together with Hassell H. Mcclellan's EUR 3,140 on September 30, 2016. Against them, 8 open-market purchases amount to EUR 85,622 (median EUR 10,286), or 67% of trades.
The three largest purchases are by James Boyle (EUR 13,839 on January 4, 2016), Dean Garfield (Director, EUR 13,697 on January 2, 2024) and Noni L. Ellison (Director, EUR 10,833 on December 23, 2024). Kenneth J. Phelan, Thomas Rowe Wright and William K. Bacic have one purchase each. From December 23, 2024 to January 14, 2025, 2 filers bought for EUR 20,656.
Read moreShow less
The record has 12 filings from 9 filers, published from January 4, 2016 to January 27, 2026, with 3 filings in 2022 and 2 in both 2024 and 2025. The US fund, listed on Nasdaq, is valued at USD 790.8 million. Publication comes a median of 2 days after the trade. A single filing, a purchase, falls within the last twelve months.
